financetom
Business
financetom
/
Business
/
Scholar Rock's genetic disease drug meets main goal in late-stage trial
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Scholar Rock's genetic disease drug meets main goal in late-stage trial
Oct 7, 2024 4:22 AM

Oct 7 (Reuters) - Scholar Rock ( SRRK ) said on Monday

its drug met the main goal in a late-stage trial testing it on

patients with a type of genetic neuromuscular disease.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved